欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3778/001
药品名称Remurel 40 mg/ml solution for injection, pre-filled syringe
活性成分
    • glatiramer acetate 40.0 mg/ml
剂型Solution for injection in prefilled syringe
上市许可持有人Alvogen IPCO S.a.r.l. 5 Rue Heienhaff L-1736 Senningerberg Luxembourg
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Iceland (IS)
      Remurel 40 mg/ml stungulyf, lausn í áfylltri sprautu
    • Poland (PL)
      Remurel
    • Latvia (LV)
      Remurel 40 mg/ml šķīdums injekcijām pilnšļircē
    • Lithuania (LT)
      Remurel 40 mg/ml injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
      REMUREL
    • Hungary (HU)
      REMUREL 40 mg/ml oldatos injekció előretöltött fecskendőben
    • Bulgaria (BG)
      Remurel
    • Czechia (CZ)
      Remurel
    • Romania (RO)
      REMUREL 40 mg/ml soluţie injectabilă în seringă preumplută
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
      Remurel 40 mg/ml otopina za injekciju, u napunjenoj štrcaljki
许可日期2017/10/03
最近更新日期2024/03/08
药物ATC编码
    • L03AX13 glatiramer acetate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase